CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
A randomized phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy for intermediate and high risk prostate cancer: Results of SPCG-13 trial.
Author
Camilla Thellenberg-Karlsson
Claes Ginman
+7Â more
Lennart Astrom
Marie Hjälm-Eriksson
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen
Sten Nilsson
Teppo Huttunen
Timo Marttila
Widmark Anders
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Triweekly docetaxel versus biweekly docetaxel as a treatment for advanced castration resistant prostate cancer: Quality of life analysis.
Author
Akseli Hemminki
Claes Ginman
+18Â more
Fredrik Laestadius
Heikki Joensuu
Ilari Lehtinen
John McCaffrey
Katinka Sandberg
Maccon M. Keane
Marjaana Luukkaa
Paul Nyandoto
Petteri Hervonen
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen
Raija Asola
Raymond S. McDermott
Sten Nilsson
Taina Turpeenniemi Hujanen
Tiina Luukkaala
Tiina Tasmuth
Timo K. Joensuu
Ulrika Harmenberg
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
No full text
